Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2355)
All Articles published online
|
Sep 15, 2003 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ. Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 2003; 9(9): 1950-1953 [PMID: 12970882 DOI: 10.3748/wjg.v9.i9.1950] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i9/1950.htm |
| Number | Citing Articles |
| 1 |
Florence Grise, Aurélien Bidaud, Violaine Moreau. Rho GTPases in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009; 1795(2): 137 doi: 10.1016/j.bbcan.2008.12.003
|
| 2 |
Wei Wang, Ji Xiang Peng, Jie Quan Yang, Lian Yue Yang. Identification of Gene Expression Profiling in Hepatocellular Carcinoma Using cDNA Microarrays. Digestive Diseases and Sciences 2009; 54(12): 2729 doi: 10.1007/s10620-008-0667-2
|
| 3 |
Yoshihiro Minamiya, Taku Nakagawa, Hajime Saito, Ikuo Matsuzaki, Kousei Taguchi, Manabu Ito, Jun-ichi Ogawa. Increased Expression of Myosin Light Chain Kinase mRNA Is Related to Metastasis in Non-Small Cell Lung Cancer. Tumor Biology 2005; 26(3): 153 doi: 10.1159/000086487
|
| 4 |
Mark J. Hoenerhoff, Arun R. Pandiri, Stephanie A. Lahousse, Hu-Hua Hong, Tai-Vu Ton, Tiwanda Masinde, Scott S. Auerbach, Kevin Gerrish, Pierre R. Bushel, Keith R. Shockley, Shyamal D. Peddada, Robert C. Sills. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice. Toxicologic Pathology 2011; 39(4): 678 doi: 10.1177/0192623311407213
|
| 5 |
|
| 6 |
Edoardo Abeni, Alessandro Salvi, Eleonora Marchina, Michele Traversa, Bruna Arici, Giuseppina De Petro. Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells. International Journal of Oncology 2017; 51(1): 128 doi: 10.3892/ijo.2017.4019
|
| 7 |
Kaylene J. Simpson, Aisling S. Dugan, Arthur M. Mercurio. Functional Analysis of the Contribution of RhoA and RhoC GTPases to Invasive Breast Carcinoma. Cancer Research 2004; 64(23): 8694 doi: 10.1158/0008-5472.CAN-04-2247
|
| 8 |
|
| 9 |
Yoji Takami, Morihiro Higashi, Shinpei Kumagai, Paul C. Kuo, Hidetada Kawana, Keiji Koda, Masaru Miyazaki, Kenichi Harigaya. The Activity of RhoA is Correlated with Lymph Node Metastasis in Human Colorectal Cancer. Digestive Diseases and Sciences 2008; 53(2): 467 doi: 10.1007/s10620-007-9887-0
|
| 10 |
Barbara Boone, Mireille Van Gele, Jo Lambert, Marc Haspeslagh, Lieve Brochez. The role of RhoC in growth and metastatic capacity of melanoma. Journal of Cutaneous Pathology 2009; 36(6): 629 doi: 10.1111/j.1600-0560.2008.01117.x
|
| 11 |
Gert G. Van den Eynden, Steven J. Van Laere, Ilse Van der Auwera, Sofia D. Merajver, Eric A. Van Marck, Peter van Dam, Peter B. Vermeulen, Luc Y. Dirix, Kenneth L. van Golen. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment 2006; 95(3): 219 doi: 10.1007/s10549-005-9002-1
|
| 12 |
Chun‐Ming Wong, Irene O. L. Ng. Molecular pathogenesis of hepatocellular carcinoma. Liver International 2008; 28(2): 160 doi: 10.1111/j.1478-3231.2007.01637.x
|
| 13 |
Yang-Yang Li, Sha Fu, Xiao-Pai Wang, Hai-Yun Wang, Mu-Sheng Zeng, Jian-Yong Shao, Hong Wanjin. Down-Regulation of C9orf86 in Human Breast Cancer Cells Inhibits Cell Proliferation, Invasion and Tumor Growth and Correlates with Survival of Breast Cancer Patients. PLoS ONE 2013; 8(8): e71764 doi: 10.1371/journal.pone.0071764
|
| 14 |
Linda Sequeira, Cara W. Dubyk, Tracy A. Riesenberger, Carlton R. Cooper, Kenneth L. van Golen. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clinical & Experimental Metastasis 2008; 25(5): 569 doi: 10.1007/s10585-008-9173-3
|
| 15 |
Jingli Du, Yulan Wang, Hanjiang Fu, Xiaofei Zheng, Minggui Lin, Mingzhou Guo, Lixin Wei. Clinical and pathological features of miR-10b and RHOC gene expression in hepatocellular carcinoma. Chinese Science Bulletin 2014; 59(19): 2249 doi: 10.1007/s11434-014-0271-0
|
| 16 |
Amra Hajdo-Milašinović, Alexander E. Mertens, Irene H. L. Hamelers, John G. Collard. Cell Motility in Cancer Invasion and Metastasis. Cancer Metastasis - Biology and Treatment 2006; 8: 189 doi: 10.1007/1-4020-4009-1_9
|
| 17 |
Amedeo Lonardo, Paola Loria. Potential for statins in the chemoprevention and management of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27(11): 1654 doi: 10.1111/j.1440-1746.2012.07232.x
|
| 18 |
Rong Chen, Yuan Cheng, Youyi Zhang, Zijian Li, Li Geng. RhoC Mediates Invasion and Migration of CaSki Cells Through the Rho-Associated Serine-Threonine Protein Kinase 1 Signaling Pathway. International Journal of Gynecologic Cancer 2014; 24(2): 184 doi: 10.1097/IGC.0000000000000053
|
| 19 |
Jing-Yu Lang, Hua Chen, Jin Zhou, Yi-Xiang Zhang, Xiong-Wen Zhang, Mei-Hong Li, Li-Ping Lin, Jin-Sheng Zhang, Michael P. Waalkes, Jian Ding. Antimetastatic Effect of Salvicine on Human Breast Cancer MDA-MB-435 Orthotopic Xenograft Is Closely Related to Rho-Dependent Pathway. Clinical Cancer Research 2005; 11(9): 3455 doi: 10.1158/1078-0432.CCR-04-2026
|
| 20 |
Carmen Chak-Lui Wong, Chun-Ming Wong, Sandy Leung-Kuen Au, Irene Oi-Lin Ng. RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it. Liver International 2010; 30(5): 642 doi: 10.1111/j.1478-3231.2010.02232.x
|
| 21 |
Mariah C. Ruth, Yisheng Xu, Ian H. Maxwell, Natalie G. Ahn, David A. Norris, Yiqun G. Shellman. RhoC Promotes Human Melanoma Invasion in a PI3K/Akt-Dependent Pathway. Journal of Investigative Dermatology 2006; 126(4): 862 doi: 10.1038/sj.jid.5700211
|
| 22 |
Devin T. Rosenthal, John Chadwick Brenner, Sofia D. Merajver. The Rho GTPases in Cancer. 2010; : 29 doi: 10.1007/978-1-4419-1111-7_2
|
| 23 |
Shuli Xie, Mingguang Zhu, Guoyue Lv, Yajun Geng, Guofu Chen, Jian Ma, Guangyi Wang, Chun-Ming Wong. Overexpression of Ras Homologous C (RhoC) Induces Malignant Transformation of Hepatocytes In Vitro and in Nude Mouse Xenografts. PLoS ONE 2013; 8(1): e54493 doi: 10.1371/journal.pone.0054493
|
| 24 |
Dongdong Qin, Kai Li, Jialin Qu, Sen Wang, Chengcheng Zou, Yanrui Sheng, Ailong Huang, Hua Tang. HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1. Archives of Virology 2013; 158(8): 1773 doi: 10.1007/s00705-013-1655-1
|
| 25 |
Na Liu, Guoyun Zhang, Feng Bi, Yanglin Pan, Yan Xue, Yongquan Shi, Liping Yao, Lina Zhao, Yi Zheng, Daiming Fan. RhoC is essential for the metastasis of gastric cancer. Journal of Molecular Medicine 2007; 85(10): 1149 doi: 10.1007/s00109-007-0217-y
|
| 26 |
Lian-Yue Yang, Wei Wang, Ji-Xiang Peng, Jie-Quan Yang, Gen-Wen Huang. Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(24): 3569-3573 doi: 10.3748/wjg.v10.i24.3569
|
| 27 |
Yang Zhao, Zhi-hong Zong, Hui-mian Xu. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9. Gynecologic Oncology 2010; 116(3): 563 doi: 10.1016/j.ygyno.2009.11.015
|
| 28 |
Wei Wang, Fan Wu, Feng Fang, Yiming Tao, Lianyue Yang. Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo
. Clinical Cancer Research 2008; 14(21): 6804 doi: 10.1158/1078-0432.CCR-07-4820
|
| 29 |
Yuanyuan Tian, Yunzhi Liu, Jialin Qu, Kai Li, Dongdong Qin, Ailong Huang, Hua Tang. HBV regulated RhoC expression in HepG2.2.15 cells by enhancing its promoter activity. Journal of Basic Microbiology 2013; 53(5): 461 doi: 10.1002/jobm.201200063
|
| 30 |
Celina G. Kleer, Kent A. Griffith, Michael S. Sabel, Gary Gallagher, Kenneth L. van Golen, Zhi-Fen Wu, Sofia D. Merajver. RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast. Breast Cancer Research and Treatment 2005; 93(2): 101 doi: 10.1007/s10549-005-4170-6
|
| 31 |
Robert Torka, Florian Thuma, Volker Herzog, Gregor Kirfel. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells. Experimental Cell Research 2006; 312(19): 3857 doi: 10.1016/j.yexcr.2006.08.025
|
| 32 |
|
| 33 |
Jing Zhang, Wen-Liang Wang, Qing Li, Qing Qiao. Expression of transforming growth factor-α and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World Journal of Gastroenterology 2004; 10(6): 830-833 doi: 10.3748/wjg.v10.i6.830
|
| 34 |
PENG-CHENG CHEN, JI-RUN PENG, LEI HUANG, WEN-XIA LI, WEN-ZHEN WANG, ZHU-QING-QING CUI, HUI HAN, LEI GONG, DA-PENG XIANG, SHI-SHI QIAO, XIN YU, YU-HUA WEI, LI-PING MA, NA LI, JI-YE ZHU, XI-SHENG LENG. Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro. Oncology Reports 2013; 30(3): 1157 doi: 10.3892/or.2013.2563
|
| 35 |
Wei Wang, Lian-Yue Yang, Zhi-Li Yang, Ji-Xiang Peng, Jie-Quan Yang. Elevated Expression of Autocrine Motility Factor Receptor Correlates with Overexpression of RhoC and Indicates Poor Prognosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2007; 52(3): 770 doi: 10.1007/s10620-006-9479-4
|
| 36 |
Q.-Y. Jiang, J.-M. Xia, H.-G. Ding, X.-W. Fei, J. Lin, R.-J. Wu. RNAi-mediated blocking of ezrin reduces migration of ectopic endometrial cells in endometriosis. Molecular Human Reproduction 2012; 18(9): 435 doi: 10.1093/molehr/gas019
|
| 37 |
Min Lin, Melinda M DiVito, Sofia D Merajver, Madanamohan Boyanapalli, Kenneth L van Golen. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1. Molecular Cancer 2005; 4(1) doi: 10.1186/1476-4598-4-21
|
| 38 |
X.R. Li, F. Ji, J. Ouyang, W. Wu, L.Y. Qian, K.Y. Yang. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2006; 32(10): 1130 doi: 10.1016/j.ejso.2006.05.012
|
| 39 |
Teresa Gómez del Pulgar, Salvador A. Benitah, Pilar F. Valerón, Carolina Espina, Juan Carlos Lacal. Rho GTPase expression in tumourigenesis: Evidence for a significant link. BioEssays 2005; 27(6): 602 doi: 10.1002/bies.20238
|
| 40 |
Hannah G. Abraham, Peter J. Ulintz, Laura Goo, Joel A. Yates, Andrew C. Little, Liwei Bao, Zhifen Wu, Sofia D. Merajver. RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.712041
|
| 41 |
Hae Il Jung, Yoon Young Choi, Moo Jun Baek, Sang Ho Bae, Sang Byung Bae, Dong Jun Jung, Sung Yong Kim, Moon Soo Lee, Moo Sik Cho, Chang Ho Kim. Expression of RhoA in Colorectal Cancers and Its Clinicopathological Significance. Journal of the Korean Society of Coloproctology 2008; 24(6): 460 doi: 10.3393/jksc.2008.24.6.460
|
| 42 |
R. Karlsson, E.D. Pedersen, Z. Wang, Cord Brakebusch. Rho GTPase function in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009; 1796(2): 91 doi: 10.1016/j.bbcan.2009.03.003
|
| 43 |
Li‐Li Wang, Zhi‐Hong Zong, Yao Liu, Xue Guan, Shuo Chen, Yang Zhao. CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR‐302e sponge to positively regulate VEGFA. Journal of Cellular and Molecular Medicine 2019; 23(12): 8472 doi: 10.1111/jcmm.14736
|
| 44 |
Keziban Unsal-Kacmaz, Shoba Ragunathan, Edward Rosfjord, Stephen Dann, Erik Upeslacis, Mary Grillo, Richard Hernandez, Fiona Mack, Anke Klippel. The interaction of PKN3 with RhoC promotes malignant growth. Molecular Oncology 2012; 6(3): 284 doi: 10.1016/j.molonc.2011.12.001
|
| 45 |
Chen Peng, Peng Gu, Jing Zhou, Jianhua Huang, Wei Wang, Qingbo Xu. Inhibition of Rho-Kinase by Fasudil Suppresses Formation and Progression of Experimental Abdominal Aortic Aneurysms. PLoS ONE 2013; 8(11): e80145 doi: 10.1371/journal.pone.0080145
|
| 46 |
Hui Li, Karine Peyrollier, Gülcan Kilic, Cord Brakebusch. Rho GTPases and cancer. BioFactors 2014; 40(2): 226 doi: 10.1002/biof.1155
|
| 47 |
Moumita Chatterjee, Linda Sequeira, Mashariki Jenkins-Kabaila, Cara W. Dubyk, Surabhi Pathak, Kenneth L. van Golen. Individual Rac GTPases Mediate Aspects of Prostate Cancer Cell and Bone Marrow Endothelial Cell Interactions. Journal of Signal Transduction 2011; 2011: 1 doi: 10.1155/2011/541851
|
| 48 |
Alampady K. Shanbhogue, Srinivasa R. Prasad, Naoki Takahashi, Raghunandan Vikram, Dushyant V. Sahani. Recent Advances in Cytogenetics and Molecular Biology of Adult Hepatocellular Tumors: Implications for Imaging and Management. Radiology 2011; 258(3): 673 doi: 10.1148/radiol.10100376
|
| 49 |
Shuli Xie, Mingguang Zhu, Guoyue Lv, Qiang Zhang, Guangyi Wang. The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells. Medical Oncology 2012; 29(3): 1802 doi: 10.1007/s12032-011-0003-0
|
| 50 |
Daniel R. Croft, Erik Sahai, Georgia Mavria, Shuixing Li, Jeff Tsai, William M. F. Lee, Christopher J. Marshall, Michael F. Olson. Conditional ROCK Activation
In vivo
Induces Tumor Cell Dissemination and Angiogenesis. Cancer Research 2004; 64(24): 8994 doi: 10.1158/0008-5472.CAN-04-2052
|
| 51 |
Jongyun Heo, Michael Wey, Inpyo Hong. Insight into the 6-Thiopurine-Mediated Termination of the Invasive Motility of Tumor Cells Derived from Inflammatory Breast Cancer. Biochemistry 2011; 50(25): 5731 doi: 10.1021/bi200347y
|
| 52 |
Matthew D. Nitz, Michael A. Harding, Dan Theodorescu. Small GTPases in Disease, Part B. Methods in Enzymology 2008; 439: 219 doi: 10.1016/S0076-6879(07)00417-X
|
| 53 |
Lui Ng, Virginia Kwan, Ariel Chow, Thomas Chung-Cheung Yau, Ronnie Tung-Ping Poon, Roberta Pang, Wai-Lun Law. Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5919-3
|
| 54 |
Pavana Thomas, Annapurna Pranatharthi, Cecil Ross, Sweta Srivastava. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1327-4
|